Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient mice
Authors
Keywords
Adipocyte differentiation, BSCL, Insulin resistance, Lipodystrophy, Lipolysis, Liver steatosis, Lipoprotein clearance, Seipin, Thiazolidinedione, Triacylglycerol
Journal
DIABETOLOGIA
Volume 56, Issue 8, Pages 1813-1825
Publisher
Springer Nature
Online
2013-05-16
DOI
10.1007/s00125-013-2926-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Magnetic Resonance Imaging Analysis of Food-Related Brain Activity in Patients with Lipodystrophy Undergoing Leptin Replacement Therapy
- (2012) Daisuke Aotani et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Seipin: from human disease to molecular mechanism
- (2012) Bethany R. Cartwright et al. JOURNAL OF LIPID RESEARCH
- Berardinelli-Seip Congenital Lipodystrophy 2/Seipin Is a Cell-Autonomous Regulator of Lipolysis Essential for Adipocyte Differentiation
- (2012) W. Chen et al. MOLECULAR AND CELLULAR BIOLOGY
- Thiazolidinediones and PPARγ agonists: time for a reassessment
- (2012) Bertrand Cariou et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Seipin ablation in mice results in severe generalized lipodystrophy
- (2011) X. Cui et al. HUMAN MOLECULAR GENETICS
- A role for seipin in lipid droplet dynamics and inheritance in yeast
- (2011) H. Wolinski et al. JOURNAL OF CELL SCIENCE
- Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis
- (2011) Weihua Fei et al. JOURNAL OF LIPID RESEARCH
- Seipin, adipogenesis and lipid droplets
- (2011) Weihua Fei et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy
- (2010) B. Victoria et al. DIABETIC MEDICINE
- Resistance to leptin-replacement therapy in Berardinelli–Seip congenital lipodystrophy: an immunological origin
- (2010) Jacques Beltrand et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-γ and Interfering with the Wnt/β-Catenin Pathways
- (2010) Mouaadh Abdelkarim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peroxisome proliferator-activated receptor-γ regulates the expression and function of very-low-density lipoprotein receptor
- (2009) Huan Tao et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Seipin deficiency alters fatty acid Δ9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy
- (2009) Emilie Boutet et al. BIOCHIMIE
- The Human Lipodystrophy Gene Product Berardinelli-Seip Congenital Lipodystrophy 2/Seipin Plays a Key Role in Adipocyte Differentiation
- (2009) Weiqin Chen et al. ENDOCRINOLOGY
- Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy
- (2009) Yukiko K. Hayashi et al. JOURNAL OF CLINICAL INVESTIGATION
- The Human Lipodystrophy Gene BSCL2/Seipin May Be Essential for Normal Adipocyte Differentiation
- (2008) V. A. Payne et al. DIABETES
- Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast
- (2008) Weihua Fei et al. JOURNAL OF CELL BIOLOGY
- Association of a Homozygous Nonsense Caveolin-1 Mutation with Berardinelli-Seip Congenital Lipodystrophy
- (2008) C. A. Kim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation